WEEKLY TOP 5
YOUR WEEKLY UPDATES FROM SHEBA MEDICAL CENTER
ARC at Sheba Medical Center & China Medical University (Taiwan) Create Partnership to Advance Digital Health Transformation in Asia-Pacific
ARC, the global healthcare transformation engine and innovation arm of Sheba Medical Center, announced the signing of a Memorandum of Understanding (MOU) with China Medical University (CMU) to establish a strategic partnership for planning a new ARC site within CMU’s Biopark. This collaboration will serve as a cornerstone for advancing digital transformation, translational research, and healthcare innovation across Taiwan and the Asia-Pacific region.
The partnership brings together CMU’s position as Taiwan’s leading biotechnology hub with ARC’s proven global model for clinician-led healthcare innovation. Under the leadership of Chairman Chang-Hai Tsai, CMU Biopark has emerged as Asia’s premier biotechnology center and the nation’s first university-based Biopark, demonstrating CMU’s commitment to integrating academic excellence with industry collaboration and clinical advancement.
The agreement establishes a framework for creating an innovation ecosystem where academia, industry, and healthcare providers converge to drive digital health transformation. The new ARC site will leverage both institutions’ strengths in clinical expertise, big data analytics, artificial intelligence, and biotechnology to accelerate the development and implementation of breakthrough healthcare technologies.
President of CMU, Prof. Mien-Chie Hung, and Founder and Director of ARC, Prof. Eyal Zimlichman, jointly announced the MOU signing, marking the beginning of this landmark collaboration that positions Taiwan as a globally connected health innovation hub.
Prof. Mien-Chie Hung, President of China Medical University, said: “The collaboration with ARC at Sheba Medical Center aligns perfectly with CMU’s mission to lead healthcare innovation in Asia. By combining our clinical expertise and research excellence with ARC’s proven innovation model, we will establish a sustainable ecosystem that empowers the next generation of healthcare solutions. This partnership will accelerate medical development not only in Taiwan but across the entire region.”
Prof. Eyal Zimlichman, Chief Innovation, Transformation, and AI Officer, and Founder and Director of ARC, Sheba Medical Center, said: “This partnership represents a significant expansion of ARC’s global network and our commitment to transforming healthcare worldwide through innovation and cross-industry global collaboration. CMU’s exceptional research capabilities and established biotechnology ecosystem make it an ideal partner to drive digital health transformation across the Asia-Pacific region. Together, we will create new pathways for clinicians, researchers, and entrepreneurs to deliver breakthrough solutions that improve patient care.”
This collaboration is part of ARC’s continued global expansion, with additional international ARC site agreements expected to be announced in 2025.
Also in this week’s edition, Prof. Yitshak Kreiss narrates what makes Sheba a hospital with “global impact”, as well as our medical experts explaining how to confront various maladies impacting global health.
When A Hospital is More Than A Hospital
Is Another Global Epidemic Starting in China?
Prof. Leshem On Measles Outbreak
Prof. Ben-Horin on Gastroenterology Breakthroughs
Prof. Zimlichman in New England Journal of Medicine
More Posts
Twinning and Training: Scalable Solutions for Global Eye Cancer Equity
Sheba Global Ophthalmology (SGO) demonstrates how sustainable twinning and hands-on training create self-reliant ocular oncology capacity in low- and middle-income countries (LMICs), far surpassing the limitations of short-term outreach.
ARC Launches HaMeirim: Sheba’s New Cardiovascular Innovation Center
Sheba Medical Center’s ARC innovation arm has launched and inaugurated HaMeirim – ARC Cardiovascular (“The Radiant Ones” or “Those who shine”), a dedicated innovation center for the Heart, Thorax, and Vascular Center.
Understanding HIV, AIDS, and Prevention with Professor Itsik Levi
In a new “Doctor on Call” video, Professor Itsik Levi, director of the HIV and STDs clinic at Sheba Medical Center, addresses common questions about HIV and AIDS and highlights why early testing is so important. He explains that being HIV-positive means living with the virus, while AIDS refers to a stage of severe immune system damage in which the body can no longer fight off everyday infections.
